Skip to main content
. 2021 Jul 19;14:17562864211030365. doi: 10.1177/17562864211030365

Figure 3.

Figure 3.

Kaplan–Meier survival curves from masitinib NPP subgroup long-term OS analysis. (a) NPP-M4.5 versus masitinib-naïve PBO. (b) NPP-ALL versus masitinib-naïve PBO.